AstraZeneca $1.5B Cancer Investment, Aquamarine Light Show Over Spain, Neuralink approved for 2nd implant, Spinal Cord Recovery Breakthrough, and more...
Manage episode 419367813 series 3533034
brief.news에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 brief.news 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
(0:10): AstraZeneca to Invest $1.5B in Singapore for Revolutionary Cancer Drug Manufacturing Facility
(1:43): Stunning Aquamarine Light Show Over Spain and Portugal Highlights Urgency for Better Space Object Detection
(3:29): Neuralink Gains FDA Nod for Second Human Brain Implant, Targets 10 Patients by Year-End
(5:31): Breakthrough Electrical Stimulation Device Offers New Hope for Spinal Cord Injury Recovery
(8:07): Groundbreaking Research Reveals Superheated Core of 'Warm Neptune' WASP-107 b, Challenging Planet Formation Theories
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Quartz
…
continue reading
(1:43): Stunning Aquamarine Light Show Over Spain and Portugal Highlights Urgency for Better Space Object Detection
(3:29): Neuralink Gains FDA Nod for Second Human Brain Implant, Targets 10 Patients by Year-End
(5:31): Breakthrough Electrical Stimulation Device Offers New Hope for Spinal Cord Injury Recovery
(8:07): Groundbreaking Research Reveals Superheated Core of 'Warm Neptune' WASP-107 b, Challenging Planet Formation Theories
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Quartz
136 에피소드